首页> 美国卫生研究院文献>Journal of Medical Toxicology >Two Cases of Refractory Cardiogenic Shock Secondary to Bupropion Successfully Treated with Veno-Arterial Extracorporeal Membrane Oxygenation
【2h】

Two Cases of Refractory Cardiogenic Shock Secondary to Bupropion Successfully Treated with Veno-Arterial Extracorporeal Membrane Oxygenation

机译:静脉动脉体外膜氧合治疗安非他酮继发难治性心源性休克2例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Bupropion inhibits the uptake of dopamine and norepinephrine. Clinical effects in overdose include seizure, status epilepticus, tachycardia, arrhythmias, and cardiogenic shock. We report two cases of severe bupropion toxicity resulting in refractory cardiogenic shock, cardiac arrest, and repeated seizures treated successfully. Patients with cardiovascular failure related to poisoning may particularly benefit from extracorporeal membrane oxygenation (ECMO). These are the first cases of bupropion toxicity treated with veno-arterial EMCO (VA-ECMO) in which bupropion toxicity is supported by confirmatory testing. Both cases demonstrate the effectiveness of VA-ECMO in poisoned patients with severe cardiogenic shock or cardiopulmonary failure.
机译:安非他酮抑制多巴胺和去甲肾上腺素的摄取。药物过量的临床影响包括癫痫发作,癫痫持续状态,心动过速,心律不齐和心源性休克。我们报告了两例严重的安非他酮毒性反应,导致难治性心源性休克,心脏骤停和反复发作成功治疗。与中毒相关的心血管衰竭患者可能特别受益于体外膜氧合(ECMO)。这是用静脉-动脉EMCO(VA-ECMO)治疗的安非他酮毒性的首例,其中通过验证性测试支持了安非他酮毒性。这两个案例都证明了VA-ECMO在严重心源性休克或心肺功能衰竭的中毒患者中的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号